As of the latest Form 4 filed Jun 8, 2026.
What Scholar Rock Holding Corp insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 15 most recent filings for SRRK.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | 2026-06-04 | FLIER JEFFREY S. Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Reed Joshua Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Brudnick Richard Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Burow Kristina Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Gilman Michael Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | Peng Katie Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-08 | 2026-06-04 | AKKARAJU SRINIVAS Director | AAward | +6.84K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | Burow Kristina Director | MExercise | +18.0K | $8.36 | $150K | No | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | Burow Kristina, Director | MExercise | +36.0K | $9.11 | $328K | No | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | Burow Kristina, Director | MExercise | +28.0K | $4.75 | $133K | No | Form 4 ↗ |
| 2026-04-24 | 2026-04-23 | Burow Kristina, Director | MExercise | +7.80K | $26.78 | $209K | No | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | Woods Keith Chief Operating Officer | SSale | −10.2K | $49.57 | $507K | No | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | Vaishnaw Akshay President of R&D | SSale | −12.2K | $49.57 | $607K | No | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | Sinha Vikas Chief Financial Officer | SSale | −10.4K | $49.57 | $516K | No | Form 4 ↗ |
| 2026-04-20 | 2026-04-16 | Hallal David Chief Executive Officer | SSale | −30.6K | $49.57 | $1.52M | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also SRRK’s full analysis or the market-wide insider trading feed. The tabs above jump to SRRK’s other SEC data.
Source: SEC Form 4 filings for SRRK, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.